Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CHYMASE Angiotensin-(1-12) Axis in Cardiovascular Disease

NCT03826745 is registered in ClinicalTrials.gov with Trinity Hypertension & Metabolic Research Institute as lead sponsor.

NCT NCT03826745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03826745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CHYMASE Angiotensin-(1-12) Axis in Cardiovascular Disease
Lead sponsor
Trinity Hypertension & Metabolic Research Institute
Phase
Observational
Overall status
Unknown status
Start date
February 11, 2019
Completion date
December 31, 2019
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease